Checkout

medical-care.webp

Periodic Paralysis Treatment Market Size, By Product Type (Beta-Blockers, Carbonic Anhydrase Inhibitor, Others), By Application (Hypokalemic Periodic Paralysis, Hyperkalemic Periodic Paralysis, Thyrotoxic Periodic Paralysis, Others), By Key Players (Strongbridge Biopharma, Sun Pharmaceutical Industries Ltd, Mylan N.V., Cadila Healthcare, Alembic Pharmaceuticals, Teva Pharmaceutical Industries Ltd, X-GEN Pharmaceuticals, Inc), By Regional Outlook And Competitive Landscape

Report ID - RV240141 | Publish Date - Jan 2024 | Pages - 175 | Price - $3260
Billing Information
Choose Licence Type
$3260
$4760
$6260
Single
$3260
Payment Method

We Accept

payment-logo